Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
Engineered 'starter key' for brain tumor offers new model for drug testing
Researchers have applied a new way to trigger medulloblastoma in neural cells that will lead to the ability to test a promising class of anti-tumor drugs.
-
St. Jude CEO James Downing ranked No. 5 of Glassdoor’s Top 100 CEOs
Under Downing’s leadership, St. Jude has increased employee feedback channels and forums, resulting in more innovation and connectivity across the Memphis-based campus.
-
Researchers develop a better method to compare gene expression in single cells
Check out a new algorithm that is available at no cost to help researchers get the most out of single-cell RNA sequencing technology.
-
St. Jude partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers in the United States
Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers
-
Rigorous study finds widely used treatment for infection fails young cancer patients
Study found ethanol-lock therapy failed to prevent new or recurring infections in cancer patients with central venous catheters and led to more complications.
-
Pediatric cancer research highlighted at ASCO Annual Meeting
St. Jude experts share pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Oncology.
